Cutler Group LP Fibrogen Inc Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Fibrogen Inc stock. As of the latest transaction made, Cutler Group LP holds 900 shares of FGEN stock, worth $8,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares

900

Previous 3,400 73.53%

Holding current value

$8,325

Previous $3,000 33.33%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$0.73 - $2.73 $1,825 - $6,825	-2,500 Reduced 73.53%	900 $2,000
Q3 2023 Nov 07, 2023	SELL	$0.79 - $2.83 $5,688 - $20,376	-7,200 Reduced 67.92%	3,400 $2,000
Q2 2023 Jul 18, 2023	BUY	$2.49 - $20.59 $20,169 - $166,779	8,100 Added 324.0%	10,600 $28,000
Q1 2023 May 01, 2023	SELL	$15.95 - $25.18 $22,330 - $35,252	-1,400 Reduced 35.9%	2,500 $46,000
Q4 2022 Feb 07, 2023	SELL	$13.27 - $17.73 $1,327 - $1,773	-100 Reduced 2.5%	3,900 $62,000
Q2 2022 Aug 04, 2022	SELL	$7.94 - $12.96 $10,480 - $17,107	-1,320 Reduced 24.81%	4,000 $42,000
Q1 2022 Apr 14, 2022	SELL	$12.02 - $16.79 $320,958 - $448,326	-26,702 Reduced 83.39%	5,320 $63,000
Q4 2021 Jan 18, 2022	BUY	$9.93 - $15.39 $237,614 - $368,267	23,929 Added 295.68%	32,022 $451,000
Q3 2021 Oct 26, 2021	BUY	$10.18 - $26.64 $21,378 - $55,944	2,100 Added 35.04%	8,093 $82,000
Q2 2021 Jul 19, 2021	BUY	$18.57 - $35.68 $92,720 - $178,150	4,993 Added 499.3%	5,993 $159,000
Q1 2020 May 07, 2020	SELL	$23.3 - $45.96 $226,732 - $447,236	-9,731 Reduced 90.68%	1,000 $34,000
Q4 2019 Feb 06, 2020	BUY	$34.58 - $48.06 $314,020 - $436,432	9,081 Added 550.36%	10,731 $460,000
Q3 2019 Oct 28, 2019	BUY	$36.98 - $48.45 $57,318 - $75,097	1,550 Added 1550.0%	1,650 $61,000
Q2 2019 Aug 09, 2019	SELL	$35.13 - $55.53 $145,789 - $230,449	-4,150 Reduced 97.65%	100 $4,000
Q1 2019 May 10, 2019	SELL	$42.83 - $59.91 $115,641 - $161,757	-2,700 Reduced 38.85%	4,250 $230,000
Q4 2018 Feb 05, 2019	BUY	$37.97 - $60.16 $233,515 - $369,984	6,150 Added 768.75%	6,950 $321,000
Q2 2018 Aug 10, 2018	BUY	$44.9 - $64.95 $13,470 - $19,485	300 Added 60.0%	800 $50,000
Q1 2018 May 11, 2018	SELL	$45.35 - $61.65 $439,396 - $597,326	-9,689 Reduced 95.09%	500 $23,000
Q4 2017 Jan 17, 2018	SELL	$41.95 - $60.1 $394,833 - $565,661	-9,412 Reduced 48.02%	10,189 $482,000
Q3 2017 Oct 17, 2017	BUY	$33.4 - $53.9 $654,673 - $1.06 Million	19,601	19,601 $1.05 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

Call Options Held

35K

Put Options Held

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $867M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account